跳至主要内容
临床试验/ISRCTN38196008
ISRCTN38196008已完成未知

A pilot study regarding regional anticoagulation by a citrate containing dialysis fluid

Albert Schweitzer Hospital0 个研究点目标入组 12 人开始时间: 2021年7月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Hemodialysis patients
  • 2. Older than 18 years
  • 3. Cardiovascular stable during and after their hemodialysis sessions
  • 4. Taking acenocoumarol, fenprocoumon, acetylsalicylic acid, dipyridamol, clopidogrel, prasugrel or a combination here of
  • 5. Good functioning arteriovenous shunt or fistula (blood flow >450 ml/min) for dialysing with two needles or double lumen hemodialysis catheter (blood flow >250ml/min)

排除标准

  • 1. Unable to give informed consent
  • 2. Unstable during hemodialysis i.e. Drop of blood pressure, muscular cramps
  • 3. With an increased risk of being unstable during hemodialysis
  • 4. With predialysis an ionized calcium <1.0 mmol/l
  • 5. With changes in their dialysis protocol during the study i.e. Change of type and/or size of dialyzer, or change in blood- and/or dialysis fluid flow or change of dialysis modality (hemodialysis, hemofiltration, hemodiafiltration) or change in ultrafiltration
  • 6. With a decrease in Hb >0.5 mmol/l during the study
  • 7. With an increase of erythropoietin dosage >25% during the study
  • 8. With a dysfunctioning arteriovenous shunt or fistula or hemodialysis catheter (see inclusion criteria)
  • 9. With a coagulation defect not to be attributed to the used medication

研究者

相似试验